316 related articles for article (PubMed ID: 33320999)
1. Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature.
Rew L; Young CC; Monge M; Bogucka R
Child Adolesc Ment Health; 2021 Feb; 26(1):3-14. PubMed ID: 33320999
[TBL] [Abstract][Full Text] [Related]
2. Puberty Assessment and Consideration of Gonadotropin-Releasing Hormone Agonists in Transgender and Gender-Diverse Youth.
Lee JY
Pediatr Ann; 2023 Dec; 52(12):e462-e466. PubMed ID: 38049185
[TBL] [Abstract][Full Text] [Related]
3. Growth in Transgender/Gender-Diverse Youth in the First Year of Treatment With Gonadotropin-Releasing Hormone Agonists.
Schulmeister C; Millington K; Kaufman M; Finlayson C; Kennedy JO; Garofalo R; Chan YM; Rosenthal SM
J Adolesc Health; 2022 Jan; 70(1):108-113. PubMed ID: 34315674
[TBL] [Abstract][Full Text] [Related]
4. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
[TBL] [Abstract][Full Text] [Related]
6. Mental Healthcare Utilization of Transgender Youth Before and After Affirming Treatment.
Hisle-Gorman E; Schvey NA; Adirim TA; Rayne AK; Susi A; Roberts TA; Klein DA
J Sex Med; 2021 Aug; 18(8):1444-1454. PubMed ID: 34247956
[TBL] [Abstract][Full Text] [Related]
7. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
[TBL] [Abstract][Full Text] [Related]
8. Association of Pubertal Blockade at Tanner 2/3 With Psychosocial Benefits in Transgender and Gender Diverse Youth at Hormone Readiness Assessment.
McGregor K; McKenna JL; Williams CR; Barrera EP; Boskey ER
J Adolesc Health; 2024 Apr; 74(4):801-807. PubMed ID: 38099903
[TBL] [Abstract][Full Text] [Related]
9. Growth, growth potential, and influences on adult height in the transgender and gender-diverse population.
Roberts SA; Carswell JM
Andrology; 2021 Nov; 9(6):1679-1688. PubMed ID: 33969625
[TBL] [Abstract][Full Text] [Related]
10. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
[TBL] [Abstract][Full Text] [Related]
11. Transgender Dependent Adolescents in the U.S. Military Health Care System: Demographics, Treatments Sought, and Health Care Service Utilization.
Van Donge N; Schvey NA; Roberts TA; Klein DA
Mil Med; 2019 May; 184(5-6):e447-e454. PubMed ID: 30325452
[TBL] [Abstract][Full Text] [Related]
12. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
13. Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study.
Olson-Kennedy J; Chan YM; Garofalo R; Spack N; Chen D; Clark L; Ehrensaft D; Hidalgo M; Tishelman A; Rosenthal S
JMIR Res Protoc; 2019 Jul; 8(7):e14434. PubMed ID: 31290407
[TBL] [Abstract][Full Text] [Related]
14. Transgender and gender-diverse youth: an update on standard medical treatments for gender dysphoria and the sociopolitical climate.
Arnold JC; McNamara M
Curr Opin Pediatr; 2023 Aug; 35(4):423-429. PubMed ID: 37097294
[TBL] [Abstract][Full Text] [Related]
15. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
[TBL] [Abstract][Full Text] [Related]
16. Commentary: The Signal and the Noise-questioning the benefits of puberty blockers for youth with gender dysphoria-a commentary on Rew et al. (2021).
Clayton A; Malone WJ; Clarke P; Mason J; D'Angelo R
Child Adolesc Ment Health; 2022 Sep; 27(3):259-262. PubMed ID: 34936180
[TBL] [Abstract][Full Text] [Related]
17. Hormone Therapy in Children and Adolescents.
Abramowitz J
Endocrinol Metab Clin North Am; 2019 Jun; 48(2):331-339. PubMed ID: 31027543
[TBL] [Abstract][Full Text] [Related]
18. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
[TBL] [Abstract][Full Text] [Related]
19. Transgender and Gender Nonconforming Youth.
Forcier M; Olson J
Adolesc Med State Art Rev; 2014 Aug; 25(2):377-97. PubMed ID: 27132320
[No Abstract] [Full Text] [Related]
20. Pubertal Suppression, Bone Mass, and Body Composition in Youth With Gender Dysphoria.
Navabi B; Tang K; Khatchadourian K; Lawson ML
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34497118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
